Company Search:
Advanced Search
Sponsored Links
Recordati SpA Company Snapshot
Recordati SpA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Recordati SpA with three other pharmaceutical manufacturers in Europe: Krka DD Novo Mesto of Slovenia (2016 sales of 1.17 billion Euro [US$1.27 billion] ), Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag of Hungary (389.69 billion Hungarian Forints [US$1.36 billion] ), and Orion Oyj which is based in Finland (1.07 billion Euro [US$1.16 billion] of which 95% was Pharmaceuticals Business).

Sales Analysis. During the year ended December of 2016, sales at Recordati SpA were 1.15 billion Euro (US$1.25 billion). This is an increase of 10.1% versus 2015, when the company's sales were 1.05 billion Euro. This was the fifth consecutive year of sales increases at Recordati SpA (and since 2011, sales have increased a total of 57%). Sales of Orphan Drugs saw an increase that was more than double the company's growth rate: sales were up 22.0% in 2016, from 153.13 million Euro to 186.81 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Recordati SpA
  Stock Performance Chart for Recordati SpA
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 31.66
(Figures in Euro)
1 Week -0.8%   13 Weeks 7.3%  
4 Weeks 17.6%   52 Weeks 47.5%  
Recordati SpA Key Data:
  Ticker: REC Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,153,942,000
(Year Ending Jan 2017).
Employees: 4,116
  Currency: Euro Market Cap: 6,497,705,084
  Fiscal Yr Ends: December Shares Outstanding: 205,233,894
  Share Type: Azioni Ordinarie Closely Held Shares: 107,216,376
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.